Browsing Category

44033 posts
PayerMax Makes a Strong Debut at G-STAR Korea, Championing Seamless Global Payment Solutions for the Gaming Industry

PayerMax Makes a Strong Debut at G-STAR Korea, Championing Seamless Global Payment Solutions for the Gaming Industry

SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ — PayerMax, a leading global…
Arctech's SkyWings Empowers the World's Largest Single-Capacity PV Power Plant Built on Coal Mining Subsidence Area

Arctech's SkyWings Empowers the World's Largest Single-Capacity PV Power Plant Built on Coal Mining Subsidence Area

ORDOS, China, Nov. 17, 2024 /PRNewswire/ — Arrctech, the world’s solar tracking…
Viettel Cyber Security Launches Free Cyber Threat Check Service in the Philippines–70% of Companies at the 21st ITIP National Conference 2024 Face Cyber Threat Risks

Viettel Cyber Security Launches Free Cyber Threat Check Service in the Philippines–70% of Companies at the 21st ITIP National Conference 2024 Face Cyber Threat Risks

MANILA, Philippines, Nov. 18, 2024 /PRNewswire/ — In just the first half…

Xinhua Silk Road: Jing'an District of China's Shanghai shines at import expo

BEIJING, Nov. 18, 2024 /PRNewswire/ — During the recently-concluded seventh China International…

Boehringer Ingelheim Commits to Veeva Vault CRM

Top biopharma company selects the next generation of CRM for life sciences as…
MUSINSA Launches the Year's Biggest Sale Event – Monster Sale Offering on Popular K-Brands

MUSINSA Launches the Year's Biggest Sale Event – Monster Sale Offering on Popular K-Brands

SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ — MUSINSA, Korea’s leading online…

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV, Israel, Nov. 18, 2024 /PRNewswire/ — SoniVie Ltd., a medical device…

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

Single dose of RN0191 achieved up to 95% individual maximum and 87%…